Novo Nordisk is discontinuing one of its discounted insulin brands, Levemir, because of manufacturing issues, decreasing patient coverage, and the availability of alternative treatments.

Nonprescription insulin ... long it works in your body. If you’re switching from newer formulations to OTC insulin, you may need to adjust your dosing schedule. For example, Sack says the short ...

Three U.S. Senators say they are "alarmed" Novo Nordisk discontinued U.S. sales of a popular insulin brand and are demanding ... to discontinue Levemir, a long-acting insulin, "failed to take ...

Use of the long-acting insulin analogs glargine and detemir does not reduce the risk of diabetic ketoacidosis in children and adolescents with type 1 diabetes mellitus (T1DM), compared with the ...

Basaglar is a long-acting insulin that may be available through Medicare Part D. If a person’s drug plan includes Basaglar, the plan cannot charge more than $35 per month. Basaglar is a brand ...

The FDA approved its short-acting insulin, Fiasp (insulin aspart injection) in September, and its long-acting insulin ... safe and effective alternatives to brand name drugs approved through ...

In an awake individual, mild-to-moderate nocturnal hypoglycemia is easily corrected by ingesting a snack containing approximately 5 g of fast-acting carbohydrate ... the basal insulin, a bedtime ...

Should a Combined Basal and Prandial Insulin Regimen Be Used? A combination of long-acting insulin once a day and preprandial rapid-acting insulin is considered an ideal regimen since it mimics ...